Walgreens Boots Alliance Inc (NASDAQ:WBA) Q2 2023 Earnings Call dated Mar. 28, 2023. Corporate Participants: Tiffany Kanaga -- Vice President, Global Investor Relations Rosalind
Walgreens Boots Alliance Inc (WBA) Q2 2023 Earnings Call Transcript
Categories
Health Care
Neogen Corporation (NEOG) Q3 2023 Earnings Call Transcript
Neogen Corporation (NASDAQ: NEOG) Q3 2023 earnings call dated Mar. 30, 2023 Corporate Participants: Bill Waelke -- Vice President, Investor Relations John Adent -- Chief Executive
AngioDynamics Inc. (ANGO) Q3 2023 Earnings Call Transcript
AngioDynamics Inc. (NASDAQ: ANGO) Q3 2023 earnings call dated Mar. 30, 2023 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
ANGO Earnings: AngioDynamics reports loss for Q3; revenue up 9%
AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported a wider loss for the third quarter when the medical device maker's revenues increased by
TC BioPharm develops safer, less expensive products to target more cancers: CEO Bryan Kobel
TC BioPharm (NASDAQ: TCBP) is a clinical-stage cell therapy company focused on the development of treatments for infectious diseases, including advanced allogeneic
TRxADE HEALTH Inc (MEDS) Q4 2022 Earnings Call Transcript
TRxADE HEALTH Inc (NASDAQ:MEDS) Q4 2022 Earnings Call dated Mar. 27, 2023. Corporate Participants: Prashant Patel -- Chief Financial Officer Surendra Ajjarapu -- Founder, Chairman and
WBA Earnings: All you need to know about Walgreens Boots Alliance’s Q2 2023 earnings results
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported second quarter 2023 earnings results today. Sales increased 3.3% year-over-year to $34.9 billion. Net earnings
Earnings: Trxade Health (MEDS) reports 16% rise in FY22 revenue; loss narrows
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a double-digit increase in revenues for fiscal 2022. The company's
Walgreens Boots Alliance (WBA) shifts to expansion mode. Will it pay off?
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in retail pharmacy, has regularly revised its business model to better align with
Ocean Biomedical presents novel malaria therapeutic discoveries at NIH Laboratory of Malaria Vaccinology and Immunology
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharma company that works with research universities and medical centers for developing and commercializing their
RVL Pharmaceuticals plc (RVLP) Q4 2022 Earnings Call Transcript
RVL Pharmaceuticals plc (NASDAQ: RVLP) Q4 2022 earnings call dated Mar. 20, 2023 Corporate Participants: Lisa Wilson -- Investor Relations Brian Markison -- Chief Executive Officer
HEXO Corp (HEXO) Q2 2023 Earnings Call Transcript
HEXO Corp (NYSE: HEXO) Q2 2023 earnings call dated Mar. 17, 2023 Corporate Participants: Charlie Bowman -- President and Chief Executive Officer Julius Ivancsits -- Chief
Cipher Pharmaceuticals Inc (CPH) Q4 2022 Earnings Call Transcript
Cipher Pharmaceuticals Inc (TSE: CPH) Q4 2022 earnings call dated Mar. 17, 2023 Corporate Participants: Craig Mull -- Interim Chief Executive Officer Bryan Jacobs -- Chief
BioLife Solutions Inc (BLFS) Q4 2022 Earnings Call Transcript
BioLife Solutions Inc (NASDAQ: BLFS) Q4 2022 earnings call dated Mar. 16, 2023 Corporate Participants: Troy Wichterman -- Chief Financial Officer Michael Rice -- Chairman and
Fundamental Research Corp. initiates coverage of Ocean Biomedical (OCEA) with “Buy” recommendation
Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday said that Fundamental Research Corp. initiated equity analyst coverage of its stock with a “Buy”
ANI Pharmaceuticals Inc (ANIP) Q4 2022 Earnings Call Transcript
ANI Pharmaceuticals Inc (NASDAQ:ANIP) Q4 2022 Earnings Call dated Mar. 09, 2023. Corporate Participants: Judy DiClemente -- Investor Relations Nikhil Lalwani -- President and Chief Executive
Ocean Biomedical provides positive research data on anti-tumor pathway; stock climbs
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) released details of discoveries that have potential applications for tumor suppression across multiple cancer pathways.
Cara Therapeutics Inc (CARA) Q4 2022 Earnings Call Transcript
Cara Therapeutics Inc (NASDAQ:CARA) Q4 2022 Earnings Call dated Mar. 06, 2023. Corporate Participants: Chris Posner -- President and Chief Executive Officer Ryan Maynard -- Chief
Patterson Companies Inc (PDCO) Q3 2023 Earnings Call Transcript
Patterson Companies Inc (NASDAQ: PDCO) Q3 2023 earnings call dated Mar. 02, 2023 Corporate Participants: John Wright -- Vice President, Investor Relations Don Zurbay -- President
Jazz Pharmaceuticals PLC (JAZZ) Q4 2022 Earnings Call Transcript
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Q4 2022 Earnings Call dated Mar. 01, 2023. Corporate Participants: Darren Fox -- Executive Director, Investor Relations Bruce C. Cozadd -- Chairman
ImmunoGen Inc (IMGN) Q4 2022 Earnings Call Transcript
ImmunoGen Inc (NASDAQ:IMGN) Q4 2022 Earnings Call dated Mar. 01, 2023. Corporate Participants: Anabel Chan -- Head of Investor Relations Mark Enyedy -- President and Chief